HIV

Long-acting injections could replace daily HIV pill

A long-acting injectable antiretroviral therapy may be just as effective as a daily oral dose in treating HIV, a trial has shown.…

Three-year PrEP pilot begins in Wales

A trial has begun in Wales to assess the use of the antiretroviral combination treatment emtricitabine/tenofovir disoproxil (marketed as Truvada) for pre-exposure prophylaxis (PrEP) against HIV infection.…

Number of new HIV diagnoses in gay men falls for first time

New diagnoses of HIV in England have fallen among men who have sex with men, with the greatest decline seen in London clinics trialling pre-exposure prophylaxis (PrEP), according to figures from Public Health England.…

FDA requests first opioid removal from market after abuse sparks HIV outbreak

The US Food and Drug Administration has requested that a formulation of oxymorphone hydrochloride, marketed as Opana ER, be withdrawn from the market due to abuse, saying that the benefits of the product no longer outweigh the risks.…

HIV services need to evolve to meet new needs

A stronger, less fragmented system of HIV services is needed in order to keep pace with the changing needs of patients.…

Improved HIV care has increased life expectancy by up to ten years

Reducing the toxicity of antiretroviral drugs, improving prophylaxis and better management of comorbidities have extended life expectancy for people with HIV, study results show.…

PrEP trial to be run in Wales despite uncertainty from All Wales Medicines Strategy Group

A Wales-wide study to make the antiretroviral combination treatment Truvada available for pre-exposure prophylaxis (PrEP) against HIV infection has been announced by Vaughan Gething, Welsh health secretary.…

Scotland will fund pre-exposure prophylaxis for people at high risk of HIV

People in Scotland at risk of HIV will be able to access pre-exposure prophylaxis (PrEP) treatment on the NHS.…

What healthcare professionals can do to help limit HIV resistance

Limiting HIV resistance must not be neglected in an era where we continue to see breakthroughs in treatment for the infection once labelled a death sentence.…

NICE proposes routine HIV testing in high prevalence areas

Adults and young people who live in local authority areas where the prevalence of HIV is ranked as “extremely high” may routinely be offered a test for the virus when they are admitted to hospital or attend an emergency department, according to new proposals from the National Institute f…